Anna Sebestyén
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Oncology top 5%
- Cancer Cells and Metastasis
- Viral-associated cancers and disorders
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 17
- Glycosylation and Glycoproteins Research 7
-
- Cancer, Hypoxia, and Metabolism 16
- MicroRNA in disease regulation 6
- Co-authors
- László Kopper (27 shared papers)Titanilla Dankó (30 shared papers)Ildikó Krencz (28 shared papers)Gábor Petővári (25 shared papers)Melinda Hajdu (6 shared papers)József Tı́már (3 shared papers)Gyula Végső (7 shared papers)Gábor Barna (18 shared papers)
- Journals
- Pathology & Oncology Research (19 papers)Cancers (8 papers)International Journal of Molecular Sciences (5 papers)Scientific Reports (4 papers)Cytokine (3 papers)
- Partner nations
- HungaryUnited StatesSouth Korea
In The Last Decade
Anna Sebestyén
102 papers receiving 1.9k citations
Anna Sebestyén's Hit Papers
Peers
Comparison fields: 5 of 112
- Cancer Research 470
- Oncology 424
- Molecular Biology 1.0k
- Genetics 124
- Immunology and Allergy 67
Countries citing papers authored by Anna Sebestyén
This map shows the geographic impact of Anna Sebestyén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Sebestyén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Sebestyén more than expected).
Fields of papers citing papers by Anna Sebestyén
This network shows the impact of papers produced by Anna Sebestyén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Sebestyén. The network helps show where Anna Sebestyén may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Sebestyén, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 105 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Formation of a protein corona on the surface of extracellular vesicles in blood plasma Hit paper breakdown → | 2021 | 324 |
| 2 | 2002 | 83 | |
| 3 | 2019 | 75 | |
| 4 | 2021 | 74 | |
| 5 | 2010 | 73 | |
| 6 | 2010 | 63 | |
| 7 | Clinical importance of vascular LH/hCG receptors--a review. | 2001 | 50 |
| 8 | 2014 | 49 | |
| 9 | 2017 | 44 | |
| 10 | 1999 | 42 | |
| 11 | 2007 | 40 | |
| 12 | 2021 | 32 | |
| 13 | 2013 | 31 | |
| 14 | 2018 | 30 | |
| 15 | 2021 | 29 | |
| 16 | 2016 | 28 | |
| 17 | 2020 | 27 | |
| 18 | 2013 | 25 | |
| 19 | BCNU is a caspase-mediated inhibitor of drug-induced apoptosis. | 1998 | 25 |
| 20 | 2012 | 24 |
About Anna Sebestyén
Anna Sebestyén is a scholar working on Molecular Biology, Cancer Research, Oncology, Surgery and Pulmonary and Respiratory Medicine, having authored 105 papers that have together received 2.0k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (17 papers), Cancer, Hypoxia, and Metabolism (16 papers), Glycosylation and Glycoproteins Research (7 papers), Proteoglycans and glycosaminoglycans research (7 papers), MicroRNA in disease regulation (6 papers), Cancer Cells and Metastasis (5 papers), 3D Printing in Biomedical Research (5 papers) and Peptidase Inhibition and Analysis (5 papers). The work is most often cited by research in Cancer Research (470 citations), Oncology (424 citations), Molecular Biology (1.0k citations), Genetics (124 citations) and Immunology and Allergy (67 citations). Anna Sebestyén has collaborated with scholars based in Hungary, United States and South Korea. Frequent co-authors include László Kopper, Titanilla Dankó, Ildikó Krencz, Gábor Petővári, Melinda Hajdu, József Tı́már, Gyula Végső, Gábor Barna, Rudolf Mihalik and Ágnes Márk. Their work appears in journals such as Pathology & Oncology Research, Cancers, International Journal of Molecular Sciences, Scientific Reports and Cytokine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.